Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression: Are they all alike?
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The behavioral profiles of five clinically used selective serotonin reuptake inhibitors (SSRIs) citalopram, paroxetine, sertraline, fluvoxamine and fluoxetine, have been compared in animal models of antidepressant (mouse forced swim test), anxiolytic (exploration of black and white test box and foot-shock-induced ultrasonic vocalization in the rat) and antiaggressive (isolation-induced aggressive behavior in the mouse) activity. the results are discussed in relation to receptor binding data from the literature. Furthermore, affinities for the sigma 1 and sigma 2 binding sites are presented. Citalopram reversed the immobility induced by forced swimming with a potency similar to that of imipramine. Paroxetine, fluvoxamine and fluoxetine reversed swim-induced immobility less potently and with a maximum of 40-50% reversal. Citalopram produced a mixed anxiogenic-/anxiolytic-like response in rats tested in the two-compartment black and white box. Paroxetine induced an anxiogenic-like response at low doses and the other SSRIs were without major effects. Citalopram and paroxetine inhibited footshock-induced ultrasonic vocalization with high potencies. The dose-response curve was biphasic for citalopram with a maximum of 64% inhibition. Sertraline and fluvoxamine inhibited the vocalization less potently, and fluoxetine induced a weak inhibitory effect corresponding to a maximum of 32%. Sertraline, fluvoxamine and fluoxetine inhibited isolation-induced aggressive behavior, whereas citalopram and paroxetine were inactive. Both 5-HT1 and 5-HT2 receptors are involved, and there was a functional interaction between 5-HT1A and 5-HT2A or 5-HT2C receptors, as ritanserin potentiated the antiaggressive effect of 1,5-HTP as well as that of 8-OH-DPAT.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The FST is typically used for drug screening, but is responsive to acute administration of typical antidepressants (41); the NSFT is responsive to chronic (~3 weeks) administration of typical antidepressants, but is a model of anxiety (42,43).”
From Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation (2019) · cites this paper as [41]
Citations
Cites
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
Is the forced swimming test a suitable model for revealing antidepressant activity?
Borsini, F., & Meli, A. (1988) · Psychopharmacology · doi:10.1007/bf00176837 · Cited by 1,052
Porsolt, R. D., Bertin, A., Blavet, N., Deniel, M., & Jalfre, M. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90366-2 · Cited by 575
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · cited 6×
“However, this does not explain that some of the SSRIs are inactive as none of the SSRIs has affinity for the 5-HTIA receptor (Hyttel 1994).”
InfluentialWeber, E., Sonders, M., Quarum, M., McLean, S., Pou, S., & Keana, J. F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8784 · Cited by 376
Role of the serotonergic system in the forced swimming test
Borsini, F. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00050-b · Cited by 240
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.8.1158 · Cited by 230
Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents
Fletcher, A., Cliffe, I. A., & Dourish, C. T. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90185-m · Cited by 194
De Vry, J., Benz, U., Schreiber, R., & Traber, J. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90530-u · Cited by 176
The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice
Sánchez, C., Arnt, J., Hyttel, J., & Moltzen, E. K. (1993) · Psychopharmacology · doi:10.1007/bf02246950 · Cited by 165
Self-citation
Research works printed but not linked: 2
- Castrogiovanni P, Di-Muro A, Maremanni I (1992) Fluoxetine reduces aggressive behavior in depressive outpatients. New Trends Exp Clin Psychiat 8:57
- Sánchez C, Arnt J and Perregaard J (1994) Lu 28-179—a selective sigma ligand with potent anxiolytic effects. Soc Neurosci Abstr 20:164.16
Cited by
Items 101–200 of 256
A tale of two transmitters: serotonin and histamine as in vivo biomarkers of chronic stress in mice
Hersey, M., Reneaux, M., Berger, S. N., Mena, S., Buchanan, A. M., Ou, Y., Tavakoli, N. S., Reagan, L. P., Clopath, C., & Hashemi, P. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02508-9 · Cited by 59
He, Y., Brouwers, B., Liu, H., Liu, H., Lawler, K., de Oliveira, E. M., Lee, D.-K., Yang, Y., Cox, A. R., Keogh, J. M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02106-5 · Cited by 55
Sang, K., Bao, C., Xin, Y., Hu, S., Gao, X., Wang, Y., Bodner, M., Zhou, Y., & Dong, X. (2018) · Molecular Pain · doi:10.1177/1744806918783931 · Cited by 58
Antidepressant-like effects of the active acidic polysaccharide portion of ginseng in mice
Wang, J., Flaisher-Grinberg, S., Li, S., Liu, H., Sun, L., Zhou, Y., & Einat, H. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.07.042 · Cited by 50
“…effects (Porsolt et al., 1977; Cryan et al., 2005), and significantly increased social interactions in mice while reducing aggressive interactions, another documented effect of antidepressant drugs and mood stabilizers (Sanchez and Meier, 1997; Einat, 2007b; Coccaro et al., 2009).”
BackgroundEgashira, N., Harada, S., Okuno, R., Matsushita, M., Nishimura, R., Mishima, K., Iwasaki, K., Orito, K., & Fujiwara, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.019 · Cited by 49
Neurochemistry and Molecular Neurobiology of Aggressive Behavior
Miczek, K. A., Faccidomo, S., Fish, E. W., & DeBold, J. F. (2006) · Springer eBooks · doi:10.1007/978-0-387-30405-2_7 · Cited by 50
Brocco, M., Dekeyne, A., Papp, M., & Millan, M. J. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000236267.41806.5b · Cited by 52
Millan, M. J., Veiga, S., Girardon, S., & Brocco, M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1389-y · Cited by 48
Millan, M. J., Girardon, S., Mullot, J., Brocco, M., & Dekeyne, A. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00021-7 · Cited by 46
The antidepressant-like effect of tDCS in mice: A behavioral and neurobiological characterization
Peanlikhit, T., Waes, V. V., Pédron, S., Risold, P., Haffen, É., Etiévant, A., & Monnin, J. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.03.012 · Cited by 50
Lee, J., Kim, H., & Hyun, D.-S. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00065-9 · Cited by 46
Emotional behavior in aquatic organisms? Lessons from crayfish and zebrafish
de Abreu, M. S., Maximino, C., Banha, F., Anastácio, P., Demin, K. A., Kalueff, A. V., & Soares, M. C. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24550 · Cited by 43
“In ro‐ dents, the serotonergic system also modulates anxiety (Broekkamp, Berendsen, Jenck, & Van Delft, 1989; Griebel, 1995; Sánchez & Meier, 1997), aggression (Chiavegatto et al., 2001; Ferrari, Palanza, Parmigiani, de Almeida, & Miczek, 2005; Olivier & Mos, 1992) and social behaviors (Dekeyne,…”
Dawson, L. A., Hughes, Z. A., Starr, K. R., Storey, J. D., Bettelini, L., Bacchi, F., Arban, R., Poffe, A., Melotto, S., Hagan, J. J., et al. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.01.010 · Cited by 42
Sokolowski, J. D., & Seiden, L. S. (1999) · Psychopharmacology · doi:10.1007/s002130051155 · Cited by 46
Günther, L., Rothe, J., Rex, A., Voigt, J.-P., Millan, M. J., Fink, H., & Bert, B. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.004 · Cited by 41
“SSRIs like citalopram have been shown to decrease immobility time after acute treatment in mice (David et al., 2003; Sanchez and Meier, 1997).”
BackgroundThe usage of video analysis system for detection of immobility in the tail suspension test in mice
Juszczak, G. R., Sliwa, A., Wolak, P. P., Tymosiak-Zielinska, A., Lisowski, P., & Swiergiel, A. H. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.08.016 · Cited by 41
Dhonnchadha, B. �. N., Ripoll, N., Cl�net, F., Hascoët, M., & Bourin, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2044-y · Cited by 43
Weiner, I., Schiller, D., Gaisler-Salomon, I., Green, A., & Joel, D. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200305000-00005 · Cited by 41
Règue, M., Poilbout, C., Martin, V., Franc, B., Lanfumey, L., & Mongeau, R. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0431-8 · Cited by 39
Gupta, R., Mehan, S., Sethi, P., Prajapati, A., Alshammari, A., Alharbi, M., Al‐Mazroua, H. A., & Narula, A. S. (2022) · Brain Sciences · doi:10.3390/brainsci12030342 · Cited by 42
“A forced-swim test was performed to assess the depressive effect in OCD as SSRIs are the principal therapeutic agent used in antidepressants [86].”
MethodCrowley, J., & Lucki, I. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382278 · Cited by 38
Yang, J., Pei, Y., Pan, Y., Jia, J., Shi, C., Yu, Y., Deng, J., Li, B., Gong, X., Wang, X., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/107380 · Cited by 45
Montezinho, L. P., Miller, S., Plath, N., Hovelsø, N., Karlsson, J.-J., Witten, L. M., & Mørk, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1917-5 · Cited by 41
“It has been reported that acute SSRIs can elicit an increase (Griebel et al. 1994, 1995) or decrease (Inoue et al. 1996b; Sanchez and Meier 1997 ) in anxiety-like responses, depending on the model used.”
BackgroundSánchez, C., & Papp, M. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200004000-00003 · Cited by 39
Self-citationChronic Antidepressant Treatment in Normal Mice Induces Anxiety and Impairs Stress-coping Ability
Baek, I., Park, J. Y., & Han, P. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.156 · Cited by 44
Rogóż, Z., & Skuza, G. (2006) · PubMed · Cited by 38
Ravinder, S., Pillai, A. G., & Chattarji, S. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00088 · Cited by 44
“…anxiogenic effect of SSRIs has been demonstrated in numerous rodent models of anxiety-like behavior (Bodnoff et al., 1989; Griebel et al., 1994; Sanchez and Meier, 1997; Dekeyne et al., 2000; Kurt et al., 2000; Silva and Brandao, 2000; Bagdy et al., 2001; Belzung et al., 2001; Koks et al.,…”
Kobayashi, T., Washiyama, K., & Ikeda, K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028208 · Cited by 38
“. Animal studies have shown that sertraline has anxiolytic properties”
BackgroundA potential antidepressant activity of SA4503, a selective σ1 receptor agonist
Skuza, G., & Rogóż, Z. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200211000-00003 · Cited by 37
Larval Zebrafish as a Model for Mechanistic Discovery in Mental Health
Tan, J. X. M., Ang, R. J. W., & Wee, C. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.900213 · Cited by 40
Prus, A. J., Hillhouse, T. M., & LaCrosse, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.11.011 · Cited by 36
“, 1996), 5-HT reuptake inhibitors (Molewijk et al., 1995; Sanchez and Meier, 1997; Sanchez et al., 2003),”
Cambiaghi, M., Crupi, R., Bautista, E. L., Elsamadisi, A., Malik, W., Pozdniakova, H., Han, Z., Buffelli, M., & Battaglia, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17114074 · Cited by 39
Foster, R. H., & Goa, K. L. (1997) · CNS Drugs · doi:10.2165/00023210-199708020-00010 · Cited by 41
Burgdorf, J., Colechio, E. M., Stanton, P., & Panksepp, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160422110344 · Cited by 35
Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze
Beijamini, V., & Andreatini, R. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00097-5 · Cited by 37
Sánchez, C., Brennum, L. T., Stórustovu, S. Í., Kreilgaard, M., & Mørk, A. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.01.006 · Cited by 38
Self-citationNashed, M. G., Seidlitz, E. P., Frey, B. N., & Singh, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.040 · Cited by 41
“Two tests were used to assess behavioural despair: the automated dual-‐ sensor FST (BioSeb, Vitrolles, France) and the automated TST (BioSeb, Vitrolles, France).”
InfluentialHascoët, M., Bourin, M., & Dhonnchadha, B. Á. N. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00293-8 · Cited by 35
Juszczak, G. R., Lisowski, P., Śliwa, A. T., & Swiergiel, A. H. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.07.003 · Cited by 35
Are benzodiazepines really anxiolytic?
Ennaceur, A., Michalíková, S., van Rensburg, R., & Chazot, P. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.026 · Cited by 36
Skuza, G., & Rogóż, Z. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70181-1 · Cited by 34
Central nervous system activity of yangambin fromOcotea duckei Vattimo (Lauraceae) in mice
de Sousa, F. C. F., Pereira, B. A., Lima, V. T. M., Lacerda, C. D. G., de Melo, C. T. V., Barbosa‐Filho, J. M., Vasconcelos, S. M. M., & Viana, G. S. B. (2005) · Phytotherapy Research · doi:10.1002/ptr.1499 · Cited by 32
Arad, M., Piontkewitz, Y., Albelda, N., Shaashua, L., & Weiner, I. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.015 · Cited by 35
Kim, S.-Y., Lee, Y.-J., Kim, H., Lee, D.-W., Woo, D., Choi, C.-B., Chae, J., & Choe, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.097 · Cited by 34
Fluoxetine Disrupts the Integration of Anxiety and Aversive Memories
Degroot, A., & Nomikos, G. G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300624 · Cited by 30
Kõks, S., Beljajev, S., Koovit, I., Abramov, U., Bourin, M., & Vasar, E. (2000) · Psychopharmacology · doi:10.1007/s002130000594 · Cited by 30
Flaisher-Grinberg, S., & Einat, H. (2009) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2009.03.003 · Cited by 35
Lénárt, L., Hodrea, J., Hosszú, Á., Kőszegi, S., Zelena, D., Balogh, D. B., Szkibinszkij, E., Veres-Székely, A., Wagner, L. J., Vannay, Á., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4209-x · Cited by 31
Skuza, G., & Rogóż, Z. (2003) · PubMed · Cited by 29
Luo, Q., Kanen, J. W., Bari, A., Skandali, N., Langley, C., Knudsen, G. M., Alsiö, J., Phillips, B. U., Sahakian, B. J., Cardinal, R. N., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01762-6 · Cited by 29
Egashira, N., Matsuda, T., Koushi, E., Higashihara, F., Mishima, K., Chidori, S., Hasebe, N., Iwasaki, K., Nishimura, R., Oishi, R., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.046 · Cited by 28
Larsen, A. K., Brennum, L. T., Egebjerg, J., Sánchez, C., Halldin, C., & Andersen, P. H. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705693 · Cited by 29
Self-citationMillan, M. J., Gobert, A., Panayi, F., Rivet, J., Dekeyne, A., Brocco, M., Ortuno, J., & Cara, B. D. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008894 · Cited by 28
“As previously reported (Millan et al., 2001b, 2004a; Sánchez and Meier, 1997), pairs of mice (CD, 22–26 g, Charles River, Saint-Aubin-les-Elbeuf) were isolated in black cages for 1 month and then exposed to each other weekly for 2 months by placement of one mouse (always the same, ‘ intruder’) in…”
BackgroundBonnin, A., Zhang, L., Blakely, R., & Levitt, P. R. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.35 · Cited by 29
Peeters, D. G. A., de Boer, S. F., Terneusen, A., Newman‐Tancredi, A., Varney, M. A., Verkes, R., & Homberg, J. R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.004 · Cited by 30
“In line with the inverse relationship between 5-HT and aggression, animals chronically treated with selective serotonin reuptake inhibitors (SSRIs) (Caldwell and Miczek, 2008; Perreault et al., 2003; Pinna et al., 2003; Sánchez and Meier, 1997) as well as genetically modified serotonin transporter (SERT) knockout mice…”
BackgroundHascoët, M., & Bourin, M. (2009) · Neuromethods · doi:10.1007/978-1-60761-303-9_11 · Cited by 26
Maulvault, A. L., Santos, L. H. M. L. M., Camacho, C., Anacleto, P., Barbosa, V., Alves, R., Pousão‐Ferreira, P., Serra-Compte, A., Barceló, ., Rodríguez‐Mozaz, S., et al. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.06.004 · Cited by 32
Gobert, A., Brocco, M., Dekeyne, A., Cara, B. D., Bouchez, G., Lejeune, F., Gannon, R. L., & Millan, M. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.176 · Cited by 26
Scarborough, J., Mueller, F. S., Weber‐Stadlbauer, U., Mattei, D., Opitz, L., Cattaneo, A., & Richetto, J. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01145-7 · Cited by 27
Oral treatment with ACCUTANE® does not increase measures of anhedonia or depression in rats
Ferguson, S. A., Cisneros, F. J., Hanig, J. P., & Berry, K. J. (2007) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.09.003 · Cited by 25
Hirano, K., Kato, Y., Uchida, S., Sugimoto, Y., Yamada, J., Umegaki, K., & Yamada, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357045039 · Cited by 23
Deas, D., Randall, C. L., Roberts, J. S., & Anton, R. F. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/1099-1077(200008)15:6<461::aid-hup209>3.0.co;2-j · Cited by 65
Self-citationSilva, J., Shao, A. S., Shen, Y., Davies, D. L., Olsen, R. W., Holschneider, D. P., Shao, X. M., & Liang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01008 · Cited by 28
Hubená, P., Horký, P., Grabic, R., Grabicová, K., Douda, K., Slavík, O., & Randák, T. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112944 · Cited by 22
Sugimoto, Y., Yamamoto, M., Tagawa, N., Kobayashi, Y., Mitsui-Saitoh, K., Hotta, Y., & Yamada, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.002 · Cited by 22
Willadsen, M., Uengoer, M., Schwarting, R. K. W., Homberg, J. R., & Wöhr, M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110072 · Cited by 23
Moncek, F., Dunčko, R., & Ježová, D. (2003) · Life Sciences · doi:10.1016/s0024-3205(02)02409-8 · Cited by 25
Medeiros, J. M. B., Feitoza, E. G., Magalhães, K. M., Cabral-Filho, J. E., Manhães-de-Castro, F. M., de Castro, C. M. M. B., & Manhaes-De-Castro, R. (2004) · Nutritional Neuroscience · doi:10.1080/1028415042000194595 · Cited by 22
Fluoxetine augmentation in citalopram non-responders: pharmacokinetic and clinical consequences
Bondolfi, G., Schekter, C. L., Kosel, M., Eap, C. B., & Baumann, P. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001686 · Cited by 22
Animal Models of Bipolar Disorder: From a Single Episode to Progressive Cycling Models
Einat, H., Kofman, O., & Belmaker, R. H. (2000) · Neurobiological foundation of aberrant behaviors · doi:10.1007/978-1-4757-4860-4_10 · Cited by 21
N-ethyl-N-nitrosourea mouse mutants in the dissection of behavioural and psychiatric disorders
Keays, D. A., & Nolan, P. M. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.107 · Cited by 22
Sànchez, C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01199-0 · Cited by 21
Self-citationArtaiz, I., Zazpe, A., Innerárity, A., del Olmo, E., Díaz, Á., Ruíz-Ortega, J. Á., Castro, E., Pena, R., Labeaga, L., Pazos, Á., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0087-3 · Cited by 23
High-speed video analysis of laboratory rats behaviors in forced swim test
Yuman, N., Ishii, I., Yamamoto, K., Takaki, T., Orito, K., & Hiroshi, M. (2008) · IEEE International Conference on Automation Science and Engineering (CASE) · doi:10.1109/coase.2008.4626501 · Cited by 22
“The FST is sensitive to all major classes of antidepressant drugs [2], including tricyclics, selective norepinephrine and serotonin reuptake inhibitors, monoamine oxidase inhibitors, and atypical antidepressants [3]–[10].”
BackgroundJones, N., King, S. M., & Duxon, M. S. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200211000-00002 · Cited by 23
Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice
Goeldner, F. O., Pigatto, G., Ribeiro, A. F., Machado, H. B., & Boerngen-Lacerda, R. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.09.009 · Cited by 25
Serra, M., Salgado‐Pineda, P., Delaveau, P., Fakra, É., Gastó, C., & Blin, O. (2006) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000214799.25044.ea · Cited by 19
Serotonin is a common thread linking different classes of antidepressants
Witt, C. E., Mena, S., Holmes, J., Hersey, M., Buchanan, A. M., Parke, B., Saylor, R., Honan, L. E., Berger, S. N., Lumbreras, S., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.10.009 · Cited by 18
Mongillo, D. L., Kosyachkova, E. A., Nguyen, T. M., & Holmes, M. M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.023 · Cited by 20
Gómez-Oliver, F., & García‐García, L. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.12.007 · Cited by 18
Elfverson, M., Johansson, T., Zhou, Q., Grevès, P. L., & Nyberg, F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.005 · Cited by 20
“…been suggested that sigma receptors are involved in the development of anxiety and depression (Dhir and Kulkarni, 2007; Matsuno et al., 1996; Maurice et al., 2001; Sanchez and Meier, 1997), and cognition (Hindmarh and Hashimoto, 2010), all of which are the effects of chronic administration of AASs.”
Inagaki, H., Kiyokawa, Y., Takeuchi, Y., & Mori, Y. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.11.013 · Cited by 22
Multidimensional nature of dominant behavior: Insights from behavioral neuroscience
Murlanova, K., Kirby, M., Libergod, L., Pletnikov, M. V., & Pinhasov, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.015 · Cited by 20
Kugelberg, F. C., Apelqvist, G., & Bengtsson, F. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900603.x · Cited by 17
Wicke, K. M., Rex, A., Jongen‐Rêlo, A. L., Groth, I., & Groß, G. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0874-0 · Cited by 17
“SSRIs and the MAO inhibitor exhibited lower efficacy.”
ResultInfluentialComparison of cannabidiol to citalopram in targeting fear memory in female mice
Montoya, Z. T., Uhernik, A. L., & Smith, J. P. (2020) · Journal of Cannabis Research · doi:10.1186/s42238-020-00055-9 · Cited by 18
“…not known to produce any of the negative side effects associated with SSRI’s, which comparatively, might make it more therapeutically desirable (Mir and Taylor 1997; Spigset 1999; Teicher et al. 1990; Fergusson et al. 2005; Ravinder et al. 2011; Salchner and Singewald 2002; Sánchez and Meier 1997).”
BackgroundSánchez, C., & Mørk, A. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00037-6 · Cited by 16
Self-citationQuadros, I. M., Takahashi, A., & Miczek, K. A. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70106-5 · Cited by 21
Tomitaka, M., Tomitaka, S., Rajdev, S., & Sharp, F. R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00323-6 · Cited by 16
Psychopharmacological characterisation of the successive negative contrast effect in rats
Phelps, C. E., Mitchell, E. N., Nutt, D., Marston, H. M., & Robinson, E. S. J. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3905-2 · Cited by 15
“2000) and the light–dark exploratory test (Sanchez and Meier 1997).”
BackgroundRaz, S., & Berger, B. D. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.04.007 · Cited by 16
“…aggression and interferes with the performance of a cooperation task inmale rats (Byrd and Briner, 1999; Miachon et al., 2000; Rilke et al., 2001; Sanchez and Meier, 1997; Schuster et al., 1993; Swanson and Schuster, 1987; Vale and Montgomery, 1997; Valzelli, 1971;Willner et al.,…”
InfluentialAguilar‐Martínez, I. S., Reyes‐Méndez, M. E., Herrera-Zamora, J. M., Osuna‐López, F., Virgen‐Ortiz, A., Mendoza‐Muñoz, N., Góngora-Alfaro, J. L., Moreno-Galindo, E. G., & Alamilla, J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05528-6 · Cited by 15
“In line with the dose-dependent effect of Cit to reduce the immobility of mice in the FST (Sánchez and Meier 1997), this SSRI also diminished the immobility of rats in the FST, in a dose-dependent manner (10–50 mg/kg).”
ResultAutomated experimental system capturing three behavioral components during murine forced swim test
Hayashi, E., Shimamura, M., Kuratani, K., Kinoshita, M., & Hara, H. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.12.016 · Cited by 15
Role of CCK in anti-exploratory action of paroxetine, 5-HT reuptake inhibitor
Kõks, S., Bourin, M., Võikar, V., Soosaar, A., & Vasar, E. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001297 · Cited by 15
Silkstone, M., & Brudzyński, S. M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.04.009 · Cited by 19
Cold-Restraint Stress-Induced Ultrasonic Vocalization as a Novel Tool to Measure Anxiety in Mice
Yamauchi, T., Yoshioka, T., Yamada, D., Hamano, T., Ohashi, M., Matsumoto, M., Iio, K., Ikeda, M., Kamei, M., Otsuki, T., et al. (2022) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b21-00776 · Cited by 19
Selectivity of SSRIs: individualising patient care through rational treatment choices
Stahl, S. (2004) · International journal of psychiatry in clinical practice · doi:10.1080/13651500410005487 · Cited by 14
Shock priming enhances the efficacy of SSRIs in the foot shock-induced ultrasonic vocalization test
Kassai, F., & Gyertyán, I. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.10.012 · Cited by 14
“Similar to our results, in the protocols described by De Vry et al. (1993) and Sanchez (1993), fluoxetine and sertraline only partially inhibited USV (De Vry et al., 1993, 2004; Sanchez and Meier, 1997; Schreiber et al., 1998).”
BackgroundMethodResultInfluentialTuerke, K. J., Leri, F., & Parker, L. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.05.011 · Cited by 13
Rzhevsky, D. I., Zhokhov, S. S., Бабиченко, И. И., Goleva, A. V., Гончаренко, Е. Н., Baizhumanov, A. A., Мурашев, А. Н., Липкин, В. М., & Kostanyan, I. A. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.11.005 · Cited by 13
Metadata
- Authors
- Sánchez, C., & Meier, E.
- Affiliations
- Lundbeck (Denmark) (DK)
- ORCID
- Sánchez, Connie
- Venue
- Psychopharmacology
- Published
- 1997-09
- Volume
- 129
- Issue
- 3
- Pages
- 197-205
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1965879244
- Cited by
- 255
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 9 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 8 · 2014: 5 · 2013: 8 · 2012: 5
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- selective serotonin reuptake inhibitors, citalopram, paroxetine, sertraline, fluvoxamine, fluoxetine, depression, anxiety, aggression, forced swim test, isolation-induced aggression, 5-HT1 receptors, 5-HT2 receptor, antidepressant effects, anxiolytic effects
- MeSH terms
- Aggression, Animals, Anxiety, Binding, Competitive, Depression, Fluoxetine, Male, Motor Activity, Vocalization, Animal, 1-Naphthylamine, Citalopram, Fluvoxamine, Rats, Wistar, Selective Serotonin Reuptake Inhibitors, Paroxetine, Receptors, sigma, Sertraline, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.